Susann Stephan-Falkenau

The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study

Christian Boch, Jens Kollmeier, Andreas Röth et al. · BMJ Open · 2013 · 153 citations · Full text

Medicine, Genetics, Oncology +16

Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations

Felix Carl Saalfeld, Carina Wenzel, Petros Christopoulos et al. · Journal of Thoracic Oncology · 2021 · 64 citations · Full text

Medicine, Immunology, Oncology +14

Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context

Marcel Wiesweg, Fabian Mairinger, Henning Reis et al. · European Journal of Cancer · 2020 · 58 citations

Medicine, Bioinformatics, Oncology +17

Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1–High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer

Philip Bischoff, Martin Reck, Tobias R. Overbeck et al. · Journal of Thoracic Oncology · 2023 · 48 citations · Full text

Medicine, Immunology, Oncology +17

Evaluation of the effectiveness of a nationwide precision medicine program for patients with advanced non-small cell lung cancer in Germany: a historical cohort analysis

Anika Kästner, Anna Kron, Neeltje van den Berg et al. · The Lancet Regional Health - Europe · 2023 · 39 citations · Full text

Medicine, Oncology, Electronic Health Records +15